Forging a Field: the Golden Age of Iron Biology

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2008 Jul 9

PMID 18606887

Citations 236

Authors

Nancy C Andrews

Affiliations

Soon will be listed here.

Citing Articles

Metal Ion Signaling in Biomedicine.

Rodriguez R, Muller S, Colombeau L, Solier S, Sindikubwabo F, Caneque T Chem Rev. 2025; 125(2):660-744.

PMID: 39746035 PMC: 11758815. DOI: 10.1021/acs.chemrev.4c00577.

Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities.

Veglia Tranchese R, Battista S, Cerchia L, Fedele M Biomolecules. 2024; 14(11).

PMID: 39595619 PMC: 11592303. DOI: 10.3390/biom14111443.

The interplay of transition metals in ferroptosis and pyroptosis.

Vana F, Szabo Z, Masarik M, Kratochvilova M Cell Div. 2024; 19(1):24.

PMID: 39097717 PMC: 11297737. DOI: 10.1186/s13008-024-00127-9.

Prodrug-inspired adenosine triphosphate-activatable celastrol-Fe(III) chelate for cancer therapy.

Li H, Li Y, Zhang L, Wang N, Lu D, Tang D Sci Adv. 2024; 10(28):eadn0960.

PMID: 38996025 PMC: 11244545. DOI: 10.1126/sciadv.adn0960.

Continuous training in young athletes decreases hepcidin secretion and is positively correlated with serum 25(OH)D and ferritin.

Kobayashi Y, Taniguchi R, Shirasaki E, Yoshimoto Y, Aoi W, Kuwahata M PeerJ. 2024; 12:e17566.

PMID: 38948227 PMC: 11214734. DOI: 10.7717/peerj.17566.

References

Nemeth E, Valore E, Territo M, Schiller G, Lichtenstein A, Ganz T . Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2002; 101(7):2461-3. DOI: 10.1182/blood-2002-10-3235. View

Courselaud B, Pigeon C, Inoue Y, Inoue J, Gonzalez F, Leroyer P . C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J Biol Chem. 2002; 277(43):41163-70. DOI: 10.1074/jbc.M202653200. View

Gunshin H, Fujiwara Y, Custodio A, Direnzo C, Robine S, Andrews N . Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest. 2005; 115(5):1258-66. PMC: 1077176. DOI: 10.1172/JCI24356. View

Feder J, Penny D, Irrinki A, Lee V, Lebron J, Watson N . The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A. 1998; 95(4):1472-7. PMC: 19050. DOI: 10.1073/pnas.95.4.1472. View

Lawrence C, Ray S, Babyonyshev M, Galluser R, Borhani D, Harrison S . Crystal structure of the ectodomain of human transferrin receptor. Science. 1999; 286(5440):779-82. DOI: 10.1126/science.286.5440.779. View

De Domenico I, Ward D, Nemeth E, Vaughn M, Musci G, Ganz T . The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci U S A. 2005; 102(25):8955-60. PMC: 1157058. DOI: 10.1073/pnas.0503804102. View

Bonneau D, Loiseau M, Amati P, Berthier M, Oriot D, Beaumont C . Bilateral cataract and high serum ferritin: a new dominant genetic disorder?. J Med Genet. 1995; 32(10):778-9. PMC: 1051699. DOI: 10.1136/jmg.32.10.778. View

Goswami T, Andrews N . Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem. 2006; 281(39):28494-8. DOI: 10.1074/jbc.C600197200. View

Peyssonnaux C, Zinkernagel A, Schuepbach R, Rankin E, Vaulont S, Haase V . Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest. 2007; 117(7):1926-32. PMC: 1884690. DOI: 10.1172/JCI31370. View

10.

Wingert R, Galloway J, Barut B, Foott H, Fraenkel P, Axe J . Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature. 2005; 436(7053):1035-39. DOI: 10.1038/nature03887. View

11.

Johnson M, Chen J, Murchison N, Green F, Enns C . Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway. Mol Biol Cell. 2006; 18(3):743-54. PMC: 1805103. DOI: 10.1091/mbc.e06-09-0798. View

12.

Stearman R, Yuan D, Yamaguchi-Iwai Y, Klausner R, Dancis A . A permease-oxidase complex involved in high-affinity iron uptake in yeast. Science. 1996; 271(5255):1552-7. DOI: 10.1126/science.271.5255.1552. View

13.

RUSSELL E, Nash D, Bernstein S, Kent E, MCFARLAND E, Matthews S . Characterization and genetic studies of microcytic anemia in house mouse. Blood. 1970; 35(6):838-50. View

14.

Zohn I, De Domenico I, Pollock A, Ward D, Goodman J, Liang X . The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease. Blood. 2007; 109(10):4174-80. PMC: 1885502. DOI: 10.1182/blood-2007-01-066068. View

15.

Donovan A, Brownlie A, Dorschner M, Zhou Y, Pratt S, Paw B . The zebrafish mutant gene chardonnay (cdy) encodes divalent metal transporter 1 (DMT1). Blood. 2002; 100(13):4655-9. DOI: 10.1182/blood-2002-04-1169. View

16.

Feder J, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy D, Basava A . A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996; 13(4):399-408. DOI: 10.1038/ng0896-399. View

17.

Ohgami R, Campagna D, McDonald A, Fleming M . The Steap proteins are metalloreductases. Blood. 2006; 108(4):1388-94. PMC: 1785011. DOI: 10.1182/blood-2006-02-003681. View

18.

Foury F, Roganti T . Deletion of the mitochondrial carrier genes MRS3 and MRS4 suppresses mitochondrial iron accumulation in a yeast frataxin-deficient strain. J Biol Chem. 2002; 277(27):24475-83. DOI: 10.1074/jbc.M111789200. View

19.

De Domenico I, Ward D, Bonaccorsi di Patti M, Jeong S, David S, Musci G . Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 2007; 26(12):2823-31. PMC: 1894773. DOI: 10.1038/sj.emboj.7601735. View

20.

Ohgami R, Campagna D, Greer E, Antiochos B, McDonald A, Chen J . Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet. 2005; 37(11):1264-9. PMC: 2156108. DOI: 10.1038/ng1658. View